NCT05124964 Prospective Study on Quality of Life in Patients With Intracranial Germ Cell Tumors
| NCT ID | NCT05124964 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tiantan Hospital |
| Condition | Quality of Life |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2021-10-12 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2021-10-12 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose of this study is to characterize the quality of life in patients with intracranial germ cell tumors. Those findings can contribute towards a better understanding of the impact of the current treatment strategy on survivors.
Eligibility Criteria
Inclusion Criteria: * 3 years ≤ age ≤ 21 years * Newly diagnosed primary intracranial germ cell tumors * Written informed consent Exclusion Criteria: * Relapsed disease * Poor compliance
Contact & Investigator
Tao Jiang, MD, PhD
PRINCIPAL INVESTIGATOR
Beijing Tiantan Hospital
Frequently Asked Questions
Who can join the NCT05124964 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 30 Years, studying Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05124964 currently recruiting?
Yes, NCT05124964 is actively recruiting participants. Contact the research team at libo@bjtth.org for enrollment information.
Where is the NCT05124964 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05124964 clinical trial?
NCT05124964 is sponsored by Beijing Tiantan Hospital. The principal investigator is Tao Jiang, MD, PhD at Beijing Tiantan Hospital. The trial plans to enroll 150 participants.